山东大学耳鼻喉眼学报 ›› 2023, Vol. 37 ›› Issue (1): 59-63.doi: 10.6040/j.issn.1673-3770.0.2021.439

• 论著 • 上一篇    

12例原发性甲状腺鳞状细胞癌的临床及生存分析

李智林1,郑洲2,安韡3   

  1. 1.山西省肿瘤医院 头颈外科, 山西 太原 030013;
    2.山西医科大学, 山西 太原 030001;
    3.山西省人民医院 口腔颌面外科, 山西 太原 030012
  • 发布日期:2023-02-06
  • 通讯作者: 安韡. E-mail:anwei_vip@126.com
  • 基金资助:
    山西省重点研发计划项目(201903D321029)

Clinical and survival analysis of primary squamous cell carcinoma of the thyroid 12 cases

LI Zhilin1, ZHENG Zhou2, AN Wei3   

  1. 1. Department of Head and Neck Oncology, Shanxi Province Cancer Hospital, Taiyuan 030013, Shanxi, China;
    2. Shanxi Medical University, Taiyuan 030001, Shanxi, China;
    3. Department of Oral and Maxillofacial Surgery, Shanxi Provincial People's Hospital, Taiyuan 030012, Shanxi, China
  • Published:2023-02-06

PDF (PC)

334

摘要： 目的 探讨原发性甲状腺鳞状细胞癌(PSCCT)的临床特征、生存分析及预后影响因素。 方法 回顾性分析12例PSCCT患者的临床表现、甲状腺超声特点、治疗方式、组织病理学特点及预后情况。采用Kaplan-Meier 法及Log-rank 检验、Cox 比例风险回归模型进行生存分析。 结果 单因素分析显示,是否合并乳头状癌与甲状腺鳞癌总生存期(OS)相关;多因素分析显示,未合并乳头状癌是OS的危险因素。 结论 PSCCT是罕见的甲状腺恶性肿瘤,恶性程度高,病情发展迅速,预后差。临床在诊断PSCCT的同时确定其是否合并乳头状癌,选择恰当的治疗方式是提高患者生存率的关键。

关键词: 原发性甲状腺鳞状细胞癌, 危险因素, 单因素分析, 多因素分析, 生存

Abstract: Objective This study aimed to investigate the clinical characteristics, survival analysis, and factors affecting the prognosis of primary squamous cell carcinoma of the thyroid(PSCCT). Methods The preoperative clinical manifestations, thyroid ultrasound features, surgical methods and postoperative pathology of 12 patients with PSCCT admitted to the Department of Head and Neck Surgery in the hospital from January 2012 to December 2019 were retrospectively analyzed, including the immunohistochemical results, comprehensive treatment methods and prognosis. The Kaplan-Meier method, Log-rank test and Cox proportional hazard regression model were used for survival analysis. Results Univariate analysis showed that combined papillary carcinoma was associated with the overall survival(OS)in patients with PSCCT. Multivariate analysis revealed that the absence of the papillary carcinoma was a risk factor for OS. Conclusion PSCCT is a rare malignant thyroid tumor with a high degree of malignancy, rapid development and poor prognosis. If diagnosing PSCCT clinically, it is necessary to determine whether it is associated with papillary carcinoma and selecting the appropriate treatment is the key to improve the survival rate.

Key words: Primary squamous cell carcinoma of the thyroid, Risk factor, Single-factor analysis, Multivariate analysis, Survival

中图分类号: 

  • R736.1
[1] Shenoy VS, Rao RA, Kamath PM, et al. Primary squamous cell carcinoma of thyroid-A rare malignant goitre[J].Indian J Surg Oncol, 2016, 7(4): 467-469. doi:10.1007/s13193-016-0530-4
[2] 金超, 刘刚, 徐协群. 原发性和继发性甲状腺鳞状细胞癌的诊治分析[J]. 基础医学与临床, 2021, 41(4): 562-567. doi:10.16352/j.issn.1001-6325.2021.04.017 JIN Chao, LIU Gang, XU Xiequn. Squamous cell carcinoma of the thyroid gland: the analysis of primary and secondary disease[J]. Basic & Clinical Medicine, 2021, 41(4): 562-567. doi:10.16352/j.issn.1001-6325.2021.04.017
[3] Sobrinho M, Saavedra J, Tallini G, et al. Tumors of the thyroid. In pathology and genetics of tumours of endocrine organs. world health organization classification of tumours [M]. France: IARC Press, 2004
[4] Bolfi F, Domingues MAC, Sobrinho-Simões M, et al. Primary squamous cell carcinoma of the thyroid diagnosed as anaplastic carcinoma: failure in fine-needle aspiration cytology? [J]. Case Rep Pathol, 2014, 2014: 301780. doi:10.1155/2014/301780
[5] Wang WL, Ouyang QH, Meng CY, et al. Treatment optimization and prognostic considerations for primary squamous cell carcinoma of the thyroid[J]. Gland Surg, 2019, 8(6): 683-690. doi:10.21037/gs.2019.11.07
[6] Edge S, Byrd, Compton C, et al. AJCC cancer staging handbook, 6th edition[M]. New York: Springer, 2002.
[7] Syed MI, Stewart M, Syed S, et al. Squamous cell carcinoma of the thyroid gland: primary or secondary disease? [J]. J Laryngol Otol, 2011, 125(1): 3-9. doi:10.1017/S0022215110002070
[8] Limberg J, Ullmann TM, Stefanova D, et al. Prognostic characteristics of primary squamous cell carcinoma of the thyroid: a national cancer database analysis[J]. World J Surg, 2020, 44(2): 348-355. doi:10.1007/s00268-019-05098-5
[9] Ko YS, Hwang TS, Han HS, et al. Primary pure squamous cell carcinoma of the thyroid: report and histogenic consideration of a case involving a BRAF mutation[J]. Pathol Int, 2012, 62(1): 43-48. doi:10.1111/j.1440-1827.2011.02745.x
[10] Shah S, Kadakia S, Khorsandi A, et al. Squamous cell carcinoma in a thyroglossal duct cyst: a case report with review of the literature[J]. Am J Otolaryngol, 2015, 36(3): 460-462. doi:10.1016/j.amjoto.2015.01.012
[11] 刘菲, 郑宏良, 陈世彩, 等. 原发性甲状腺鳞状细胞癌[J]. 中国耳鼻咽喉头颈外科, 2007, 14(12): 691-693. doi:10.3969/j.issn.1672-7002.2007.12.001 LIU Fei, ZHENG Hongliang, CHEN Shicai, et al. Primary squamous cell carcinoma of thyroid gland[J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2007, 14(12): 691-693. doi:10.3969/j.issn.1672-7002.2007.12.001
[12] Cho JK, Woo SH, Park J, et al. Primary squamous cell carcinomas in the thyroid gland: an individual participant data meta-analysis[J]. Cancer Med, 2014, 3(5): 1396-1403. doi:10.1002/cam4.287
[13] 赵佳正, 王海滨, 韩志江, 等. 甲状腺未分化癌临床和CT特征分析[J]. 中华内分泌外科杂志, 2020, 14(4): 305-309. doi:10.3760/cma.j.issn.115807-20191205-00243 ZHAO Jiazheng, WANG Haibin, HAN Zhijiang, et al. Clinical and CT features of anaplastic thyroid carcinoma[J]. Chinese Journal of Endocrine Surgery, 2020, 14(4): 305-309. doi:10.3760/cma.j.issn.115807-20191205-00243
[14] 闫庆娜, 战忠利, 张连郁. 原发性甲状腺鳞状细胞癌-附11例临床病理分析[J]. 天津医药, 1998(11): 694-695, 676
[15] Sniezek JC, Holtel M. Rare tumors of the thyroid gland[J]. Otolaryngol Clin North Am, 2003, 36(1): 107-115. doi:10.1016/s0030-6665(02)00134-2
[16] 史业辉, 钱碧云. 原发性甲状腺鳞状细胞癌27例分析[J]. 中国肿瘤临床, 2004, 31(8):456-458. doi:10.3969/j.issn.1000-8179.2004.08.012 SHI Yehui, QIAN Biyun. Analysis of 27 cases of primary squamous cell carcinoma of thyroid[J]. Cancer Biology & Medicine, 2004, 31(8): 456-458. doi:10.3969/j.issn.1000-8179.2004.08.012
[17] Cook AM, Vini L, Harmer C. Squamous cell carcinoma of the thyroid: outcome of treatment in 16 patients[J]. Eur J Surg Oncol, 1999, 25(6): 606-609. doi:10.1053/ejso.1999.0715
[18] 唐亚玲. 原发性甲状腺鳞状细胞癌的临床诊治及生存分析[D]. 北京:北京协和医学院, 2016
[19] 周晓红, 李真华. 原发性甲状腺鳞状细胞癌4例报告[J]. 中国普外基础与临床杂志, 2001, 8(5): 347-348. doi:10.3969/j.issn.1007-9424.2001.05.029 ZHOU Xiaohong, LI Zhenhua. Primary squamous cell carcinoma of the thyroid(report of 4 cases)[J]. Chinese Journal of Bases and Clinics in General Surgery, 2001, 8(5): 347-348. doi:10.3969/j.issn.1007-9424.2001.05.029
[20] Limberg J, Ullmann TM, Stefanova D, et al. Prognostic characteristics of primary squamous cell carcinoma of the thyroid: a national cancer database analysis[J]. World J Surg, 2020, 44(2): 348-355. doi:10.1007/s00268-019-05098-5
[21] 余济春. 分化型甲状腺癌颈淋巴结清扫术[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 10-12. doi:10.6040/j.issn.1673-3770.1.2016.03 YU Jichun. Neck dissection to differentiated thyroid carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2016, 30(2): 10-12. doi:10.6040/j.issn.1673-3770.1.2016.03
[22] Cho JK, Woo SH, Park J, et al. Primary squamous cell carcinomas in the thyroid gland: an individual participant data meta-analysis[J]. Cancer Med, 2014, 3(5): 1396-1403. doi:10.1002/cam4.287
[23] Au JK, Alonso J, Kuan EC, et al. Primary squamous cell carcinoma of the thyroid: a population-based analysis[J]. Otolaryngol Head Neck Surg, 2017, 157(1): 25-29. doi:10.1177/0194599817698436
[24] 周广磊,孙甲甲,黄景昊,等.原发性甲状腺鳞癌伴胸锁乳突肌转移1例报告及文献复习[J].中国现代普通外科进展, 2021, 24(9):755-756. doi:10.3969/j.issn.1009-9905.2021.09.022 Zhou Guanglei, Sun Jiajia, Huang Jinghao, et al. A case report of primary squamous thyroid carcinoma with sternocleidomastoid metastasis and literature review[J]. Advances in Modern General Surgery in China, 2021, 24(9): 755-756. doi:10.3969/j.issn.1009-9905.2021.09.022
[1] 李爱军,崔小梅. 白内障术前房颤人群综合路径管理现状横断面调查[J]. 山东大学耳鼻喉眼学报, 2022, 36(6): 38-44.
[2] 张礼俊, 胥然, 罗继芳, 刘国旗, 何千, 李玮, 蒋振华. 头颈肿瘤游离皮瓣修复术后皮瓣坏死及皮瓣相关并发症影响因素分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 86-90.
[3] 白伶伶,王红星,王立春. 可吸收泪小管塞栓联合人工泪液治疗中重度干眼的有效性及对视觉相关生存质量的影响[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 78-82.
[4] 刘珊珊, 韩书婧, 王晓旭, 李艳红, 倪鑫, 张杰. 儿童细菌性脑膜炎后听力损害危险因素的系统评价与Meta分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 48-54.
[5] 陈国平,傅敏仪,叶飞,徐建慧. 早期声门型喉癌钬激光与CO2激光手术对比研究[J]. 山东大学耳鼻喉眼学报, 2021, 35(4): 8-11.
[6] 王中卫,杨林,郭亚,孙斌,王亚利,马秀龙,任宏涛,包兴. 鼻咽癌患者miR-429、miR-200C表达与预后关系分析[J]. 山东大学耳鼻喉眼学报, 2021, 35(3): 81-86.
[7] 黄俊伟,陈学军,刘宏飞,陶冶,李祖飞,陈平,张洋. 细胞周期蛋白E2在下咽癌中的表达及其意义[J]. 山东大学耳鼻喉眼学报, 2020, 34(5): 132-137.
[8] 杨秀芬,尤冉,马秀梅,王康,王艳玲. 以医院为基础的中心性浆液性脉络膜视网膜病变流行病学调查及危险因素的研究[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 75-79.
[9] 陈东,余红,李洋,黄强,方敏. 功能性鼻内窥镜鼻窦手术粘连的潜在危险因素及其预测价值[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 87-91.
[10] 吕静荣,陈淳,马衍,谢晋. 儿童分化型甲状腺癌的临床特征及危险因素分析[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 88-94.
[11] 郝文培, 翟华蕾, 孙晓彤, 张雅妮, 朱艳辉, 孔倩倩, 程钧, 张婷. 角膜再移植原因与植片失活的危险因素分析[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 134-140.
[12] 陈慧君,宋圣花,董伟达,周涵. 术前外周血纤维蛋白原水平对喉癌预后的影响[J]. 山东大学耳鼻喉眼学报, 2020, 34(2): 110-114.
[13] 黄河,欧阳晖. 下咽癌共病食管癌的高危因素及预后分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 82-86.
[14] 赵艳,程四华,童巧珍. 强化自我护理对喉镜辅助声带息肉切除术后患者嗓音恢复及心理情绪的影响[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 175-178.
[15] 郎永耀,杨云,刘晴,徐林弟,林子萍. 咽喉反流性疾病的影响因素及治疗效果分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 119-123.
Viewed
Full text
334
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 0 0 0 334

  From Others local
  Times 2 332
  Rate 1% 99%

Abstract
890
Just accepted Online first Issue
0 0 890
  From Others local
  Times 888 2
  Rate 100% 0%

Cited
Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发